10th Circ. Revives Genentech Cancer Drug Dosage Suit
The Tenth Circuit on Friday revived a case alleging Genentech Inc. underfilled packages of its breast cancer drug Herceptin, reversing a district court decision from last year that held the plaintiffs'...To view the full article, register now.
Already a subscriber? Click here to view full article